Cutaneous Mucinoses Flashcards

1
Q

Special stains for mucin

A

Alcian blue pH 2.5
Colloidal iron
Toluidine blue pH 4.0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is associated with a Scleromyxoedema

A
Monoclonal gammopathy (immunoglobulin G lambda)
No thyroid disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the microscopic triad of scleromyxoedema

A

Diffuse Mucin deposition (confirmed with a mucin stain)
Fibroblast proliferation (irregularly arranged fibroblasts)
Fibrosis @ increased collagen deposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical features of scleromyxoedema

A

Widespread eruption 2-3mm firm waxy closely spaced dome-shaped/flat topped papules - can be itchy
Arranged linear pattern
Surrounding skin sclerodermoid (shiny and thick)
Leonine facies (deep furrowing forehead)
Shar-pei sign (deep furrowing trunk, shoulder, limbs)
Sparse eyebrow, axillary, pubic hair
Doughnut sign over PIP joints
Sclerodactyly
Rarely Raynaud’s phenomenon
Lacks telengiectasia/calcinosis (scleroderma features)
No mucosal lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

DDx of scleromyxoedema and differences with scleromyxoedema

A

Scleroderma/systemic sclerosis (no papules, positive ANA, anticentromere, antiScl70)

Sclerodema (no papules, assoc URTI, diabetes)

Nephrogenic systemic fibrosis (no facial involvement/monoclonal gammopathy, renal dysfunction + exposure to gadolinium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Systemic involvement of scleromyxoedema

A

Haem - 100% monoclonal gammopathy, rarely others I.e. myeloma, lymphoma etc
Neuro - carpal tunnel syndrome, peripheral neuropathy, memory loss, stroke, seizures, psychosis, gait issues, vertigo, dermatoneuro syndrome)
Rheum - Arthralgias/arthritis, myopathy, myalgia
Cardiovascular - CCF, myocardial ischaemia, heart block
Pulmonary - obstructive or restrictive
GI - dysphagia
Renal - acute RF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Prognosis of scleromyxoedema

A

Chronic, progressive, unpredictable course

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes of death in scleromyxoedema

A

Dermatoneuro syndrome (concomitant fever, convulsions, coma)
Cardiovascular
Haem malignancies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Baseline investigations for scleromyxoedema

A

Skin biopsy
Serum and urine protein electrophoresis with immunofixation
TFT normal
Little value in imaging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatment ladder for scleromyxoedema

A

1st line -
IVIg 2g/kg for 5 days alone or in combo with Lenalidomide/systemic steroids - skin and extra cutaneous, esp for acute deterioration with neuro symptoms, response not permanent, maintenance infusions required every 6-8 weeks

2nd line (combined with IVIg rather than as mono therapy) -
Lenalidomide 100-400mg/day +/-
Systemic steroids

3rd line -
Autologous peripheral blood stem cell transplant
Bortezomib and dexamethesone (for recurrences and dermatoneuro syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Additional treatment for scleromyxoedema

A
Medical - 
Oral retinoids
Cyclosporin 
Interferon alpha
Hydroxychloroquine

Chemo -
Melphalan
Cyclophosphamide
MTX

Physical - 
Plasmapheresis
PUVA, UVA1
Electron beam
Extracorporeal photochemo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cutaneous mucinoses classification

A
PRIMARY MUCINOSES
Dermal
- lichen myxoedematosus (scleromyxoedema, localised lichen myxoedematosus)
- reticular erythematous mucinosis
- scleroedema 
- myxoedema in thyroid diseases (pretibial myxoedema)
- papular and nodular mucinosis in CTD
- self healing cutaneous mucinosis
- cutaneous focal mucinosis
- digital myxoid cyst

Follicular

  • Pinkus follicular mucinosis
  • Urticaria-like mucinosis

SECONDARY MUCINOSES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Localised lichen myxoedematosus clinical features

A
Small firm waxy papules, nodules, plaques confined to few sites
No sclerotic features
No paraproteinaemia
No systemic involvement
No association with thyroid disease
4 subtypes 
- acral persistent papular mucinosis
- papular mucinosis of infancy 
- discrete papular lichen myxoedematosus
- nodular lichen myxoedematosus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

4 subtypes of localised lichen myxoedematosus

A

Acral persistent papular mucinosis

Papular mucinosis of infancy

Discrete papular lichen myxoedematosus

Nodular lichen myxoedematosus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Localised lichen myxoedematosus pathology

A

Mucin in the upper and mid reticular dermis
Variable fibroblast proliferation
Fibrosis not marked/absent
Grenz zone (acral persistent papular mucinosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acral persistent papular mucinosis (subtype of localised lichen myxoedematosus)

A

Multiple ivory to skin coloured papules

Exclusive on dorsal hands, distal forearms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Discrete papular lichen myxoedematosus (subtype of localised lichen myxoedematosus)

A

Small reddish, violaceous or skin coloured papules
Trunk and limbs
Symmetrical distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Papular mucinosis of infancy (subtype of localised lichen myxoedematosus)

A

Firm opalescent papules
Neck
Trunk
Upper arms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Nodular lichen myxoedematosus (subtype of localised lichen myxoedematosus)

A

Multiple nodules
Mild/absent papular component
Trunk, limbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Localised lichen myxoedematosus associations

A

HIV
Hep C
Exposure to toxic oil/L-tryptophan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

DDx of localised lichen myxoedematosus

A

Granuloma annulare
Lichen amyloidosus
Lichen planus
Eruptive collagenoma

22
Q

Disease course of localised lichen myxoedematosus

A

Chronic but benign course, in the absence of systemic involvement

23
Q

Prognosis for localised lichen myxoedematosus

A

Progression to scleromyxoedema has never been proven

24
Q

Reticular erythematous mucinosis (REM) clinical features

A
Chronic persistent macular erythema, indurated erythematous papules/plaques
Reticular configuration 
Lack of scale
Midline back, chest
Occasionally itchy 
Sometimes face, abdomen, arms, legs
25
Reticular erythematous mucinosis (REM) associations
Generally not related to systemic diseases Not associated with abnormal lab tests ``` Malignancies - haem, breast, lung, colon HIV Thyroid dysfunction Diabetes Idiopathic thrombocytopenic Purpura SLE ```
26
Reticular erythematous mucinosis (REM) aggravating factors
``` OCP Pregnancy Menses Heat, sweat X-ray therapy Role of sunlight is controversial ``` Family Hx
27
Reticular erythematous mucinosis (REM) pathology
Epidermis normal Mucin in upper dermis Slight vascular dilatation Perivascular (sometimes perifollicular) T cell infiltrate, with variable deep extension DIF negative (rarely IgM, IgA, C3 at DEJ)
28
DDx for reticular erythematous mucinosis (REM)
Tumid lupus - clinical and histo similarities, lack immune serological abnormalities, respond well to HCQ, resolve without residual lesions (tumid lupus without reticulated lesions on the midline are strongly photosensitive, higher positive DIF, higher recurrence rate, present with other lupus features) Seb derm - central chest, scale Pityriasis versicolor - central chest, scale Confluent and reticulated papillomatosis of Gougerot-Carteaud (CARP) - scale
29
Disease course of reticular erythematous mucinosis (REM)
Chronic Prolonged duration of untreated May clear spontaneously
30
Treatment ladder for reticular erythematous mucinosis (REM)
First line HCQ 400mg daily - improvement/healing within 1-2 months Second line TCS Systemic steroid Topical calcineurin inhibitors I.e. tacrolimus, pimecrolimus Third line Phototherapy I.e. UVA1, UVB (potential for exacerbation, but successful results reported) PDL Other Oral antihistamines Tetracycline CSA
31
Scleroedema clinical features
Non-pitting swelling/induration Upper part of body (neck, shoulders, upper back) - typically begin on posterior neck, spread to scalp, shoulders, upper back Spares hands and feet Erythema Peau d’orange appearance Symmetrical, diffuse Progressive Limited body mobility/movement restriction Subtypes - Diabetic - Non diabetic (idiopathic, with preceding febrile illness/post-strep, with monoclonal gammopathy/multiple myeloma, misc conditions I.e. HIV, internal malignancy, autoimmune disorder)
32
Subtypes of scleroedema
Diabetic (poorly controlled insulin-dependent) - slowly progressive, non-resolving Non diabetic - idiopathic - with preceding febrile illness/post-strep URTI (also influenza, measles, mumps, chickenpox, CMV, diphtheria, encephalitis, dental abscess) - acute onset, complete resolution 6 months-2 years - with monoclonal gammopathy/multiple myeloma - slowly progressive, non-resolving - misc conditions I.e. HIV, internal malignancy, autoimmune disorder (RA, primary biliary cirrhosis, sjogren syndrome, dermatomyositis)
33
Scleroedema path
Normal epidermis Thickened dermis Swollen collagen fibres separated by wide spaces Mucin Subcut fat replaced by coarse collagen fibres No fibroblast proliferation
34
DDx of scleroedema
``` Systemic sclerosis (has additional sclerodactyly, Raynaud phenomenon, nail fold capillary changes, positive serum autoantibodies) Dermatomyositis Other infiltrates - - Myxoedema (mucin) - Amyloidosis (amyloid) Lymphoedema Cellulitis ```
35
Extracutaenous complications of scleroedema
``` Serositis Myositis Parotitis Hepatosplenomegaly Ocular Cardiac Dysphasia Dysarthria ```
36
Scleroedema course/prognosis
Post-infectious scleroedema - benign course, self-limiting, resolves spontaneously 6 months - 2 years Diabetes/monoclonal gammopathy associated scleroedema - chronic, little chance of remission
37
Initial investigations for scleroedema
To detect underlying disorder Throat swab, ASOT - recent strep infection Fasting blood glucose, HBA1C - diabetic control Serum, urine protein electrophoresis and immunofixation - monoclonal gammopathy, multiple myeloma USS - evaluate skin thickness at baseline, after treatment MRI - extent of disease progression (better than USS for this purpose)
38
Treatment of scleroedema
Difficult, limited success No effective treatment Some patients (but not all) diabetes patients improve with better glucose control First line - Treat underlying cause UVA1, PUVA, nb-UVB (for disabling manifestations) Physio MSK rehab (for motion/respiratory disability) Second line - Electron beam radiotherapy Extracorporeal photopheresis IVIg Third line (immunosuppressants) - CSA MTX TCS, ILCS, pred
39
Pretibial myxoedema clinical features
Bilateral shins, dorsum feet Thickened and indurated skin Orange peel appearance/texture due to prominent hair follicles Overlying hyperhidrosis or hypertrichosis 4 variants - - diffuse non-pitting oedema - plaque type - nodular type - elephantiasis Hyperthyroidism esp Graves’ disease, sometimes Hashimoto’s thyroiditis Sometimes no past/present Hx of thyroid dysfunction
40
Pretibial myxoedema path
``` Hyperkeratosis Papillomatosis Acanthosis Follicular plugging Mid to lower dermis separation of collagen bundles by mucin Perivascular lymphocytic infiltrate Increase mast cells Normal/increased fibroblasts Reduced elastic fibres ```
41
DDx for pretibial myxoedema
LSC Hypertrophic lichen planus Obesity-associated lymphoedematous mucinosis (no thyroid disease)
42
Pretibial myxoedema course/prognosis
Elephantiasis variant less likely to have remission | Entrapment of peroneal nerve by mucinous connective tissue —> foot drop, faulty dorsiflexion
43
Initial investigations for pretibial myxoedema
Biopsy Anti-TSH antibodies - high TSH - low —> high thyroid hormone to stimulate more TSH production
44
Treatment of pretibial myxoedema
General measures - Reduce weight Stop smoking Normalise thyroid function (though pretibial myxoedema can still develop after treatment started) First line - Medium to high potency TCS under occlusion ILCS Compression stockings/gradient pneumatic compression (improves lymphoedema) ``` Second/third line (only for elephantiasis variant) - Rituximab Extracorporeal plasmapheresis IVIg Octreotide +/- shave removal N.B relapse after skin graft ```
45
Papular and nodular mucinosis in connective tissue diseases features
Skin coloured papules, nodules, plaques Trunk, upper extremities Accompany/antedate connective tissue disease I.e. LE (cutaneous lupus mucinosis, usually associated with SLE but may also be associated with DLE/SCLE), dermatomyositis, scleroderma Clinical course may/may not be related to the underlying connective tissue disease activity Path - abundant mucin throughout dermis, sometimes subcut fat, slight/moderate perivascular lymphocytic infiltrate, positive lupus band General measures - sunscreen First line treatment - TCS, ILCS, HCQ Resistant cases - Pred, oral tacrolimus
46
Self-healing juvenile cutaneous mucinosis
13 months - 15 years old Acute eruption of multiple papules, sometimes linear infiltrated plaques scalp, face, neck, abdomen, thighs Subcut nodules face, periarticular areas on limbs, periorbital swelling Systemic symptoms - fevers, arthralgias, weakness, muscle tenderness No paraproteinaemia/bone marrow plasmocytosis/thyroid dysfunction Spontaneous resolution few weeks - months Avoid aggressive therapy as heals spontaneously
47
Cutaneous focal mucinosis
Benign localised cutaneous dermal mucinosis No systemic manifestations Anecdotal associations - hypothyroidism, myxoedema, scleromyxoedema, REM, anti-TNF Rx Reactive lesion Trauma may act as a trigger Asymptomatic solitary skin coloured papule/nodule, sometimes with cystic appearance Anywhere except in proximity of the joints of the hands, wrists, feet Treatment - surgical excision Path - - Diffuse ill-defined dermal mucin - Spares subcut tissue - Normal/slight increase fibroblast (spindle-shaped cells) - No inflammation - No increased vascularity - No elastic fibres - Normal/hyperplastic epidermis, sometimes forming collarette DDx - angiomyxoma (benign >1cm, subcut involvement by mucin + increased vascularity)
48
Digital myxoid cyst
Benign ganglion cyst of digits Translucent dome shaped soft/fluctuate nodule +/- visible semi transparent contents Dorsal skin/near distal interphalangeal joint Surface smooth or verrucous Clinical/radio graphic evidence of osteoarthritis Grooving of the nail may precede/associate the cyst by up to 6 months Antecedent trauma in minority of cases MRI can denote Connection of cyst to underlying joint 2 variants - Over joints - ganglion type derived from joint fluid and synovial cells Between interphalangeal joints - myxomatous type derived from dermal fibroblasts Histo - Large deposit mucin containing stellate fibroblasts Multiple clefts Vascular spaces Epidermis - atrophied centrally, acanthotic laterally Sometimes transepidermal elimination of mucin Treatment - No consistently successful treatment Excision (relapse not uncommon) Multiple needling/aspiration followed by ILCS/cryo/sclerosant/CO2 laser (favoured as a conservative alternative to excision)
49
Pinkus follicular mucinosis
Children, adults in 30s/40s Familial cases ? Genetic predisposition Acute/subacute eruption 1 or several sharply demarcated erythematous plaques with follicular prominence (more reassuring if solitary lesion on the head/neck) Alopecia Scaling Differentiation with MF-associated follicular mucinosis is difficult Histo - Mucin within follicular epithelium, sebaceous glands abusing keratinocytes to disconnect from each other Perifollicular infiltrate of lymphocytes, histiocytes, eosinophils Absence of epidermotropism/atypical lymphocytes (favour MF-associated follicular mucinosis) T cell gene rearrangement not always useful to exclude MF-associated follicular mucinosis Treatment- No specific Rx Consider wait and see - many cases heal spontaneously 2-24 months Topicals - TCS, topical calcineurin inhibitor, topical retinoids/bexarotene, imiquimod ILCS Systemic - Pred, isotretinoin, minocycline, dapsone, HCQ, interferon alpha-2b Physical - PDT, UVA1
50
Urticaria-like follicular mucinosis
Cyclic eruption of itchy urticaria-like papules/plaques Head/face/neck of middle-aged men Rosaceiform/seborrhoeic background skin Red macules persist for a few weeks as lesions resolve No follicular plugging No alopecia No systemic manifestations ``` DDx - Urticaria Seb derm Rosacea Tumid lupus ``` Histo - Mucin deposition within hair follicles Perivascular and perifollicular infiltrate of lymphocytes and eosinophils T-cell gene rearrangement polyclonal Treatment - Chronic Difficult to treat Systemic - HCQ, Dapsone